TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

GUANGZHOU NOVAKEN

Infectious DiseaseCardiovascularGastroenterology
Generics

GUANGZHOU NOVAKEN is a generic drug manufacturer focused on Infectious Disease, Cardiovascular, Gastroenterology. Key products include ESOMEPRAZOLE MAGNESIUM.

2020
Since
2
Drugs
-
Trials
42
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

POTASSIUM CHLORIDE 2025-12-22
POTASSIUM CHLORIDE 2025-11-20
POTASSIUM CHLORIDE 2025-10-27
Labeling
POTASSIUM CHLORIDE 2025-09-10
POTASSIUM CHLORIDE 2025-07-22
POTASSIUM CHLORIDE 2025-07-11
POTASSIUM CHLORIDE 2025-04-21
Labeling
ESOMEPRAZOLE MAGNESIUM 2025-04-15
ESOMEPRAZOLE MAGNESIUM 2025-04-15
POTASSIUM CHLORIDE 2025-04-09
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 30%
1 drugs
Cardiovascular 30%
1 drugs
Gastroenterology 30%
1 drugs
Neurology 10%
0 drugs Phase 2: 1

Pipeline Strength Pro

Loading...

Competitors Pro

WARNER CHILCOTT LLC specialty
Cardiovascular, Neurology, Gastroenterology, Infectious Disease
Bristol-Myers Squibb big-pharma
Gastroenterology, Infectious Disease, Neurology
GE HEALTHCARE specialty
Infectious Disease, Neurology, Cardiovascular
APOTHECON specialty
Infectious Disease, Cardiovascular, Gastroenterology
Novo Nordisk big-pharma
Cardiovascular, Infectious Disease, Neurology